DIC India Ltd Valuation Shifts Signal Renewed Price Attractiveness

Valuation Metrics Show Improved Price Attractiveness

DIC India’s price-to-earnings (P/E) ratio currently stands at 16.90, a significant improvement compared to many of its peers in the Other Chemical products industry. For context, J.G. Chemicals trades at a P/E of 31.85, Indo Borax & Chemicals at 33.57, and Titan Biotech at a lofty 48.18. Even the relatively more affordable Gulshan Polyols sports a P/E of 27.51, well above DIC India’s level. This lower P/E ratio suggests that the market is pricing DIC India’s earnings more conservatively, potentially offering a margin of safety for value-oriented investors.

The price-to-book value (P/BV) ratio of 1.21 further supports the stock’s attractive valuation status. This figure is modest compared to the sector’s more expensive names, indicating that the stock is trading close to its net asset value. Such a valuation is often appealing in cyclical or volatile sectors, where asset backing provides downside protection.

Enterprise Value Multiples Confirm Relative Cheapness

Examining enterprise value (EV) multiples, DIC India’s EV to EBITDA ratio is 8.30, markedly lower than peers such as J.G. Chemicals (23.40) and Titan Biotech (38.63). This suggests that the company’s operational earnings are being valued more conservatively by the market. The EV to EBIT ratio of 12.62 and EV to capital employed of 1.25 also reinforce this narrative of relative affordability. These multiples indicate that investors are paying less for each unit of operating profit and capital employed compared to competitors, which could signal undervaluation if the company’s fundamentals hold steady or improve.

Profitability and Growth Metrics Remain Modest

Despite the attractive valuation, DIC India’s return on capital employed (ROCE) and return on equity (ROE) remain subdued at 4.01% and 7.16% respectively. These figures lag behind what might be expected for a strong growth or high-quality company, which partly explains the cautious market stance. The company’s PEG ratio of 0.17, however, indicates that its price is low relative to expected earnings growth, suggesting potential upside if growth materialises.

Dividend yield is modest at 0.53%, reflecting a conservative payout policy or limited free cash flow generation. Investors seeking income may find this less compelling, but the focus here appears to be on valuation and growth potential rather than yield.

Stock Price and Market Performance Context

DIC India’s current share price is ₹560.35, down 2.96% on the day and below its previous close of ₹577.45. The stock has traded between ₹550.00 and ₹580.00 today, within a 52-week range of ₹452.00 to ₹630.00. This places the stock roughly 11% below its annual high, indicating some recent price pressure.

Looking at returns relative to the Sensex, DIC India has outperformed over the medium term. The stock delivered a 19.13% return over three years compared to the Sensex’s 17.67%, though it has lagged over the past year with a -3.36% return versus the Sensex’s -4.26%. Over five years, the stock’s 22.61% gain trails the Sensex’s 34.19%, highlighting mixed performance depending on the timeframe.

Mojo Score and Grade Reflect Cautious Optimism

DIC India’s current Mojo Score stands at 67.0, placing it in the Hold category, a downgrade from its previous Buy rating as of 28 Aug 2026. This shift reflects a more cautious stance by analysts, likely influenced by the company’s modest profitability and recent price weakness despite improved valuation metrics. The micro-cap status of the company also adds a layer of risk, as liquidity and volatility tend to be higher in this segment.

The downgrade signals that while the stock’s valuation has become more attractive, other factors such as earnings quality, growth prospects, and market conditions temper enthusiasm. Investors should consider these elements carefully before initiating or increasing exposure.

Peer Comparison Highlights Relative Value

When compared to its peer group, DIC India’s valuation stands out as one of the more attractive options. Several competitors are classified as expensive or very expensive, with P/E ratios often exceeding 30 and EV/EBITDA multiples above 20. For example, Indo Borax & Chemicals and Keltech Energies trade at P/E multiples of 33.57 and 50.9 respectively, with EV/EBITDA ratios above 27 and 32. This contrast underscores DIC India’s relative cheapness on a valuation basis.

However, it is important to note that some peers may justify their premium valuations through stronger growth, higher returns, or better market positioning. For instance, Titan Biotech’s elevated multiples may reflect superior earnings momentum or niche advantages. Investors should weigh these qualitative factors alongside quantitative metrics.

Investment Considerations and Outlook

For investors evaluating DIC India, the recent shift in valuation parameters offers a compelling entry point from a price perspective. The stock’s P/E and EV/EBITDA multiples are notably lower than sector averages, suggesting potential undervaluation. However, the company’s modest profitability metrics and the downgrade in Mojo Grade to Hold indicate that risks remain.

Market participants should monitor upcoming earnings releases and sector developments closely. Improvements in ROCE and ROE, alongside sustained earnings growth, could validate the current attractive valuation and potentially trigger a re-rating. Conversely, any deterioration in fundamentals or broader market weakness could weigh further on the stock.

Given the micro-cap status, liquidity considerations and volatility should also factor into investment decisions. A balanced approach, possibly incorporating position sizing and risk management, is advisable.

Summary

DIC India Ltd’s valuation has improved significantly, with key metrics such as P/E at 16.90 and EV/EBITDA at 8.30 placing it in attractive territory relative to peers. Despite this, the company’s profitability remains modest, and the recent downgrade to a Hold rating reflects cautious market sentiment. Investors seeking value in the Other Chemical products sector may find DIC India worth consideration, provided they remain mindful of the company’s growth prospects and micro-cap risks.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →